An observational study in Obesity & Overweight, sponsored by Nantes University Hospital. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.
Sponsored by Nantes University Hospital · Observational
Among 10 studies in Obesity by Nantes University Hospital — 5 open to participants now, 5 under way, none of them phase 3. Obesity · Nantes University Hospital.
Among the 10 studies in Obesity by Nantes University Hospital, this one is one of 3 that started in 2026, is one of 2 observational ones, and was the 10th registered.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
Browse Obesity studies →5 of the 10 studies in Obesity by Nantes University Hospital are open now, in 1 country. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Nantes University Hospital · Sites in France
Nantes University Hospital · Sites in France
Nantes University Hospital · Sites in France
By country, each count listing its studies:
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 168 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 3,000 is above the median of 114 across 2,154 observational studies indexed under Obesity.
Median enrollment 92 across the 8 interventional studies, 1,550 across the 2 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.
2 of the studies in Obesity by Nantes University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06271317Nantes University HospitalEvaluation of Possible Postoperative Complications After Nissen Sleeve Gastrectomy. French Multicenter Study | 2027-03 |
| NCT07423481Nantes University HospitalWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity | 2027-07-01 |
Among the 10 studies in Obesity by Nantes University Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
SEMAFOLLOW is a real-world follow-up study examining the outcomes of individuals treated with WEGOVY® (semaglutide 2.4 mg) under the temporary authorisation for use (ATU) and early access programme in France. This study evaluates weight change, treatment strategies and well-being, drawing on the expertise of teams from various specialist obesity centres in France.
Patients treated with WEGOVY® (semaglutide 2.4 mg) under temporary authorization for use (ATU) and the early access program in France.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient agreeing to participate in the SEMAFOLLOW study.
Other: SEMAFOLLOW questionnaire
If the patient agrees, the center will send a link to the questionnaires via email. Patients who have completed the questionnaires will be analyzed in the SEMAFOLLOW study. Estimated time to complete the questionnaire: approximately 30 minutes
This study also gives Semaglutide. No intervention listed here names it: that was found by reading the record.
Describe weight changes during the follow-up period according to patient characteristics.
Time frame: Baseline
Identify the characteristics of patients who continue treatment or switch to other obesity management strategies and the associated factors.
Time frame: Baseline
Compare the profiles of responders and non-responders
Time frame: Baseline
Describe weight change according to different subpopulations.
Time frame: Baseline
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Jul 2027, 9 months later.
Of 791 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 9 months is below that.
Counting every sponsor, half of 836 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.